Since my last note on Stemline Therapeutics from May 2nd 2013, the stock has rallied nearly 150%, from a previous high of $16.49/share to a new 52-week high of $39.18/share made last week.
http://seekingalpha.com/article/1644032-positive-data-and-investor-interest-uphold-stemlines-momentum?source=feed
http://seekingalpha.com/article/1644032-positive-data-and-investor-interest-uphold-stemlines-momentum?source=feed
No comments:
Post a Comment